Much of their work is in the earliest stages of development—there’s a good chance we won’t see any of them used widely in 2024 or even 2025. Some might not even pan out at all. The work that will be done over the next year is setting the stage for a massive technology boom la...
BioSpace continues to bring you the latest news and industry developments from the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco. Stay tuned!
Messenger RNA (mRNA) is an emerging class of therapeutic agent for the prevention and treatment of a wide range of diseases. The recent success of the two highly efficacious mRNA vaccines produced by Moderna and Pfizer–BioNTech to protect against COVID-19 highlights the huge potential of mRNA ...
Matthew Stenger / Monday, October 21, 2024 1:06 PM Rogaratinib/Atezolizumab in Cisplatin-Ineligible FGFR mRNA-Overexpressing Urothelial Cancer In the phase Ib FORT-2 trial reported in JAMA Oncology, Sweis et al found that the combination of the pan-FGFR inhibitor rogaratinib and atezolizumab...
Conference Programs to Optimize Your Bioprocesses 2024 Programs August 19-20 August 21-22 UPSTREAM PROCESSING DOWNSTREAM PROCESSING GENE THERAPY CELL THERAPY mRNA MANUFACTURING & DELIVERY ANALYTICAL & QUALITY STABILITY & FORMULATION DIGITALIZATION EXECUTIVE ...
Quality by Design in mRNA Manufacturing Advancing Epilepsy Research: New Strategies for Drug-Resistant Epilepsy and Associated Comorbidities Medicare Part D price negotiation update Patient First: Enhancing Strategies for Effective Patient Engagement, Recruitment and Diversity in Clinical Trials ...
August 1, 2024 -- On August 1, 2024, Angela Carini, an XX woman, and Imane Khelif, an XY intersex "woman," entered the ring for round one of their boxing match at the Paris Olympics. Less than a minute later, Miss Carini said enough and refused to fight. ...
expression of known sleep genes (Fig.3p; Supplementary Fig.18). The mRNA levels of several ion channels that promote sleep are significantly reduced compared to the GAL4 control, includingHyperkinetic(Hk),Shaker cognate l(Shal),ShabandIhwhile no significant difference was observed for known wake-...
The BioRMB™ is a column-free and steady-state purification platform that is specifically tailored for sensitive modalities such as gene therapies, vaccines, mRNA, and complex antibodies. In this work we will present the general principles of operation for the BioRMB™, as well as showcase ...
Conference abstractFull text access Ultrasound-guided Cytopathologist Performed FNA Biopsy of Ipsilateral Trunk Lymphadenopathy Following Second Dose Administration of SARS-CoV-2 mRNA Vaccine Patrick Memari, Paulo Garcia, Adele Kraft, Austin Wiles Pages S39-S40 View PDF select article Utility of Cytologic...